DSM NV (Koninklijke DSM NV) (DSMN.AS)

DSM NV (Koninklijke DSM NV) (DSMN.AS) Trading on MT5 at XM

At XM we offer DSM NV (Koninklijke DSM NV) (DSMN.AS) stocks as cash CFDs. Our cash CFDs stocks are undated transactions that aim to replicate the cash price of the underlying stock, and so they are adjusted for any relevant corporate actions.

Open a Demo Account
Open an Account

Risk warning: FX and CFD trading involves a high risk of loss.

About DSM NV (Koninklijke DSM NV) (DSMN.AS) Trading

Royal DSM NV is a multinational science-based company founded in 1902, with its headquarters in Heerlen, Netherlands. The company is specialized, among others, in producing nutritional products and ingredients; specialty food ingredients; engineering plastics; biochemical materials; and solar efficiency technology. The company stock is traded on Euronext stock exchange.

Trading Conditions

Margin requirement 10 %
Spreads as low as 0.97
Symbols DSM
Description DSM NV
Min. Price Fluctuation 0.01000
Value of Minimum Price Fluctuation EUR 0.1
Value of 1 lot 10 Shares
Min/Max Trade Size 0.4/27
Swap Value in Margin Currency Long -2.44 %
Swap Value in Margin Currency Short -3.56 %
Limit and Stop Levels** 0.05
Total Volume Limit (per client)*** 265
Weekday 10:10-18:25 (GMT +3)
Monday Open 10:10 (GMT +3)   │   Friday Close 18:25 (GMT +3)
** Min. level for placing pending orders at a current market price.

*** Note that the maximum trading volume for DSM per client is 265 lots. This limit will be reviewed on a daily basis and updated according to the value of the instrument.

How to Start Trading DSM NV (Koninklijke DSM NV) (DSMN.AS)?

Step 1

Open an XM Real Account

Step 2

Download and login to the MT5 platform

Step 3

Double-click on DSM NV (Koninklijke DSM NV) (DSMN.AS) from the “Market Watch” to open an order for this instrument.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.